FDA Import Refusal SCS-6574310-9/11/1 — Rxhomeo Private Limited
The FDA refused shipment SCS-6574310-9/11/1 from Rxhomeo Private Limited (India) on March 21, 2023. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charge: 27 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- March 21, 2023
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 66VBY99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 27